Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
3
×
biotech
boston
new york blog main
new york top stories
abbvie
acorda therapeutics
alexion pharmaceuticals
alnylam pharmaceuticals
ampyra
antisense oligonucleotide
apokyn
apomorphine
benzodiazepines
biogen
blackstone group
blackstone life sciences
boehringer ingelheim
columbia university
dalfampridine
david goldstein
deals
depression
dicerna pharamceuticals
duopa
epi4k
epilepsy
essential tremor
fda
hepatitis b
hepatitis b virus
hereditary transthyretin amyloidosis
inbrija
investing
kiran reddy
What
stop
3
×
disease
drug
medicines
new
research
acorda
aims
approved
backed
caught
cause
causing
ceo
cope
dicerna
drugs
epilepsy
episodes
eye
fda
friday
gene
genes
genetic
gets
help
hepatitis
intended
late
links
looms
marcio
meant
medications
mutations
neuro
nod
parkinson’s
patients
Language
unset
Current search:
stop
×
photo
×
" national top stories "
×
@xconomy.com
3 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
